GeneDx Holdings WGS
NASDAQ WGS
$66.29 +2.68 (+4.21%)
At close: Oct 19, 2026 · 4:00 PM EDT

GeneDx Holdings (WGS) Current Deferred Revenue (2020 - 2022)

Updated

GeneDx Holdings' Current Deferred Revenue was $40,000 in Q4 2022, down 91.5% from $473,000 a year earlier.

Analysis

GeneDx Holdings (WGS) Current Deferred Revenue (2020 - 2022) Analysis & Trends

From Q4 2020 onward, GeneDx Holdings has reported Current Deferred Revenue for 7 quarters.

  • In earlier years, Current Deferred Revenue was $473,000 in FY2021 (-73.7%) and $1.8 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 100.51 Bn 96.52 Bn -
2 Natera 57.27 Bn 52.95 Bn 485.19 Mn
3 Quest Diagnostics 26.09 Bn 24.22 Bn 1.03 Bn
4 Labcorp Holdings 26.08 Bn 23.83 Bn 1.11 Bn
5 Tenet Healthcare 22.29 Bn 11.30 Bn -
6 Guardant Health 21.03 Bn 17.09 Bn 219.03 Mn
7 Fresenius Medical Care AG 12.78 Bn 4.73 Bn 1.52 Bn
8 BrightSpring Health Services 12.65 Bn 10.98 Bn 492.75 Mn
9 Davita 12.13 Bn 9.34 Bn 1.16 Bn
10 GeneDx Holdings 1.96 Bn 1.33 Bn 78.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 40,000.00
Mar 31, 2022 100,000.00
Dec 31, 2021 473,000.00
Sep 30, 2021 493,000.00
Jun 30, 2021 1.34 Mn
Mar 31, 2021 2.81 Mn
Dec 31, 2020 1.80 Mn
API Access

GeneDx Holdings Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=WGS&period=max&api_key=YOUR_API_KEY